FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system
about
Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer ProgressionMolecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesUrokinase receptor and resistance to targeted anticancer agentsIdentification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factorShort hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.Plectin as a prognostic marker in non-metastatic oral squamous cell carcinomaMiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)Integrated analysis of transcription factor, microRNA and LncRNA in an animal model of obliterative bronchiolitisProtein-DNA array-based identification of transcription factor activities differentially regulated in obliterative bronchiolitis.Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition.Quantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migration.Vitamin D receptor signaling and pancreatic cancer cell EMT.Expression and potential correlation among Forkhead box protein M1, Caveolin-1 and E-cadherin in colorectal cancerFOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesisTransforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.Expression of FoxM1 and the EMT-associated protein E-cadherin in gastric cancer and its clinical significance.The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition.Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study.MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.Long non-coding RNA CCAL/miR-149/FOXM1 axis promotes metastasis in gastric cancerLong non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway
P2860
Q26768428-1B556BFF-8AA2-400A-B192-D665AEC1AA3DQ26774636-DD9F47E0-44AB-47AD-82F9-7F9AF9895C1FQ26797385-ECDE495C-7114-4254-B2F8-6735B72B3302Q30354565-C57A239D-BCB2-4A24-9C26-5BD197EA4287Q35234273-EE215A1E-DEB5-401B-91AF-278D2B7FAE6AQ35595144-B4792DD0-0BF1-484C-8734-576DFE15D7C0Q35755113-5418747D-2361-44D6-BE98-3DC136F4236BQ35781321-423F4273-FF00-474C-8839-CB162F50370FQ35919272-D6C4A39B-F335-41E9-9F52-46F6B549E51EQ35919314-CDDF825F-E50B-45AF-B3EE-DE17CACF830CQ35929853-107F367F-4D0B-4C91-92BA-A09E44262EE3Q36511744-AD5DEC6A-7590-4093-8DBD-13D8B802F40AQ36935182-91F0C8CA-6A43-4277-B424-999EE36A1B78Q37288489-D52F137E-F582-4F7A-BF04-3EADCD503F67Q37295427-F7AA68A5-1B36-4B23-9CC3-C793A5D23D85Q37588256-6E713299-CB9F-4FBF-9F8C-AEE40DFE89C3Q37716906-3318C43A-B990-47A6-A2C0-4A283FD11791Q39443785-517A3DA0-92E7-4FEA-BD36-2D2C29FFF883Q41195919-56158247-F990-4434-872F-296D6E75AD8EQ45068538-7A3217ED-4B7C-48FF-9C2F-9E474B514A32Q47123091-7D040DD3-A359-4B53-A8D8-6318346FB845Q47126059-B284DBEA-9D9C-4699-97C0-4CE98D637724Q50071615-07525436-D399-4A7E-8FE3-5B558521133BQ57151262-66F16197-072B-4551-9EA3-C4FA44EF98D0Q58573269-616DBB12-F0A7-4152-A8DA-F3591192C897
P2860
FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FOXM1c promotes pancreatic can ...... e plasminogen activator system
@en
FOXM1c promotes pancreatic can ...... plasminogen activator system.
@nl
type
label
FOXM1c promotes pancreatic can ...... e plasminogen activator system
@en
FOXM1c promotes pancreatic can ...... plasminogen activator system.
@nl
prefLabel
FOXM1c promotes pancreatic can ...... e plasminogen activator system
@en
FOXM1c promotes pancreatic can ...... plasminogen activator system.
@nl
P2093
P2860
P1476
FOXM1c promotes pancreatic can ...... e plasminogen activator system
@en
P2093
P2860
P304
P356
10.1158/1078-0432.CCR-13-2311
P407
P577
2014-01-22T00:00:00Z